SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933
SEC Accession No. 0001193125-04-208689
Filing Date
2004-12-07
Accepted
2004-12-07 14:58:14
Documents
5
Filing Date Changed
2004-12-07

Document Format Files

Seq Description Document Type Size
1 INITIAL FILING ds3.htm S-3 326567
2 FORM OF INDENTURE dex44.htm EX-4.4 336992
3 OPINION OF NUTTER MCCLENNEN & FISH LLP dex5.htm EX-5 11918
4 STATEMENT RE COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES dex12.htm EX-12 42441
5 CONSENT OF ERNST & YOUNG LLP dex232.htm EX-23.2 1996
  Complete submission text file 0001193125-04-208689.txt   722176
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: S-3 | Act: 33 | File No.: 333-121050 | Film No.: 041188364
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1